HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

AIDS

Volumn 13, Issue 11, 1999, Pages 1305-1311

  Abebe, Almaz ^a   Demissie, Dereje ^a,b   Goudsmif, Jaap ^a,b,c   Brouwer, Margreet ^a,b,c   Kuiken, Carla L ^a,b,c,d   Pollakis, Georgios ^a,b,c,d,e   Schuitemaker, Hanneke ^a,b,c,d   Fontanet, Arnaud L ^a,b   De Rinke Wit, Tobias F ^a,b  

^a ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d CENTRAL LABORATORY   (Netherlands)

^e LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

AIDS; C subtype; Coreceptor; Ethiopia; HIV 1; NSI; SI

Indexed keywords

CHEMOKINE RECEPTOR; GLYCOPROTEIN GP 120; PHYTOHEMAGGLUTININ;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; ETHIOPIA; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; PHENOTYPE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNCYTIUM; VIRUS LOAD;

ADULT; CROSS-SECTIONAL STUDIES; DNA, VIRAL; ETHIOPIA; FEMALE; GIANT CELLS; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LEUKOCYTES, MONONUCLEAR; MALE; PEPTIDE FRAGMENTS; PHENOTYPE; PHYLOGENY; RECEPTORS, HIV; RNA, VIRAL; SEQUENCE ANALYSIS, DNA;

EID: 0032866483     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199907300-00006     Document Type: Article

References (53)

1. Asjo B, Albert J, Karlsson A, el aJ. Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV-1 infection. Lancet 1986, ii:660-662.
2. Coffin JM. HIV-1 population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995, 267:483-489.
3. Schuitemaker H, Koot M, Kootstra NA, et al. Biological phenotype of human immunodeficiency virus type 1 clones at different stage of infection: progression of disease is associated with a shift from monocytotropic to T-cell tropic virus populations.; Virol 1992, 66:1354-1360.
4. Tersmette M, de Coede REY, Al BJM, et al. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AlDS-related complex. ; Virol 1988, 62:2026-2032.
5. Zhu T, Mo H, Wang N, e( al. Genotypic and phenotypic characterization on HIV-1 in patients with primary infection. Science 1993, 261:1179-1181.
6. Koot M, Vos AHV, Keet RPM, et al. HIV-1 biological phenotype in long term infected individuals, evaluated with an MT-2 cocultivation assay. AIDS 1992, 6:49-54.
7. Spijkerman IJ, Koot M, Prins M, et al. Lower prevalence and incidence of HIV-1 syncytium-inducing phenotype among injecting drug users compared with homosexual men. AIDS 1995,9:1085-1092.
8. Yu XF, Wang Z, Beyrer C, et al. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. ] Virol 1995, 69:4649-4655.
9. Tersmette M, Lange JMA, de Coede REY, e( aJ. Differences in risk for AIDS and AIDS mortality associated with biological properties of HIV variants, iancet 1989, i:983-985.
10. Cheng-Mayer C, Seto D, Tateno M, Levy JA. Biologic features of HIV-1 that correlate with virulence in the host. Science 1988, 240:80-82.
11. Andeweg AC, Leeflang P, Osterhaus AD, Bosch ML. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprolein functionally interact with other envelope regions in syncylium formation.; Virol 1993, 67:3232-3239.
12. Fouchier RAM, Cronenink M, Kootstra NA, et al. Phenotype associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. I Virol 1992, 66:3183-3187.
13. Yoshimura K, Matsushita S, Hàyashi A, Takatsuki K. Relationship of HIV-1 envelop V2 and V3 sequences of the primary isolates to the viral phenotype. Microbiol Immunol 1996, 40:277-287.
14. Zhong P, Peelers M, Janssens W, et al. Correlation between genetic and biological properties of biologically cloned HIV-1 type 1 viruses representing subtypes A, B, and D. AIDS Res Hum Relrovir 1995, 111:239-248.
15. de Jong JJ, Simon F, van der Groen G, et al. V3 loop sequence analysis of seven HIV-1 type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells. AIDS Res Hum Retrovir 1996, 12:16:1503-1507.
16. de Wolf F, Hogervorst E, Goudsmit J, et al. Syncytium-inducing and non-syncytium inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res Hum Retrovir 1994, 10:1387-1400.
17. Choe H, Farzan M, Sun Y, et al. The /3-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
18. Deng H, Liu R, Ellmeier VV, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
19. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and /J-chemokine receptors CKR-5, CKR-3 and CKR-2b as fusin cofactors. Cell 1996, 85:1149-1158.
20. Liao F, Alkhatib G, Peder KW, et aJ. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line tropic HIV-1. J Exp Med 1997,85:2015-2023.
21. Eshete H, Sahlu T. The progression of HIV/AIDS in Ethiopia. E Mop I Health Dev 1996, 10:179-190.
22. Fontanet AL, Messele T, Dejene A, et al. Age-and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. AIDS 7998, 12:315-322.
23. Abebe A, Kuiken CL, Coudsmit J, et al. HIV type 1 subtype C in Addis Ababa, Ethiopia. AIDS Res Hum Retrovir 1997, 13:1071-1075.
24. Ajehunie S, Johansson B, Sonnerborg A, et al. Sequence analysis of selected regions of the env (V3 loop and gp41) and gag (p7) reading frames of Ethiopian human immunodeficiency virus type 1 strains. Arch Vim! 1993, 128:229-239.
25. Sherefa K, Sonnerborg A, Steinbergs J, Sallberg M. Rapid grouping of HIV-1 infection in subtypes A to E by V3 peptidc serotyping and its relation to sequence analysis. /oc/iem Biophys Res Commun 1994, 205:1658-1664.
26. Abdool Karim Q. XII Conference on AIDS. Geneva, Junel 998.
27. World Health Organization. Weekly epidemiological record. 1990,29:221-224.
28. Centers for Disease Control and Prevention. Revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (H1V) infection. MMWR 1997,46:1-19.
29. Kievit T, van Cemen B, van Strijp D, et al. NASBA TM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. ] Virol Methods 1991, 35:273-286.
30. Boom R, Sol CJA, Salimans MMM, et aJ. Rapid and simple method for purification of nucleic acids. ] Clin Microbiol 1990, 28:495-503.
31. Root M, van't Wout AB, Kootstra NA, et al. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. I Infect Dis 1996, 173:349-354.
32. van't Wout, AB, Blaak, H, Ran LJ, et al. Evolution of syncytiuminducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection. I Virol 1998, 72:5099-5107.
33. Bjorndal A, Deng, H, Jansson M et al. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. ] Virol 1997, 71:7478-7487.
34. Kumar S, Tamura K, Nei M. Molecular evolutionary genetics analysis (MEGA). Version 7.07. Philadelphia, PA: Institute of Molecular Evolutionary Genetics, Pennsylvania State University; 1993.
35. Kimura M. Estimation of evolutionary distances between homologous nucleotide sequences. Proc Natl Acad Sei USA 1981, 78:454-458.
36. Felsenstein ). PHYLIP-phylogeny inference package. Version 3.57c. 1995.
37. Stapleton el al. XII Conference on AIDS. Geneva, June1998 [abstract 21111].
38. Tscherning C, Alaeus A, Fredriksson R, et al. Differences in chemokine co-receptor usage between genetic subtypes of HIV-1. Virology 1998, 241:181 -188.
39. Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV co-receptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Nail Acad Sei USA 1997,94:1925-1930.
40. Messele, T, Abdulkadir, M, Fontanet F, et al. Reduced naive and increased CD27 negative CD4 and CDS cells in the blood of healthy adult Ethiopians. Clin Exp Immun 1999,115:443-450.
41. Bentwich Z, Kalinkovich A, Weisman Z, Grossman Z. Immune activation in the context of HIV infection. Clin Exp Immunol 1998, 111:1-2.
42. Rizzardini, G, Piconi S, Ruzzante S, et al. Immunological activation markers in the serum of African and European HIVseropositive and séronégative individuals. AIDS 1996, 10:1535-1542.
43. Actor JK, Shirai M, Kullberg MC el al. Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Thl cytokine responses as well as delayed virus clearance. Proc Nail Acad Sei USA 1993, 90:948-952.
44. de Husman RAM, Koot M, Cornelissen, et al. Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Inlern Med 1997, 127:882-890.
45. Lasky M, Perret JL, Peelers M, et al. Presence of multiple non-B subtypes and divergent subtype B strains of HIV-1 in individuals infected after overseas deployment. AIDS 1997, 11:43-51.
46. Jameel S, Zafrullah M, Ahmed M, Kapoor SG, Sehgal S. A genetic analysis of HIV-1 from Punjab, India reveals the presence of multiple variants. AIDS 1995, 9:685-690.
47. Chi-Chang Luo, Tian C, Hu DJ, el al. HIV-1 subtype C in China, lancet 1995, 345:1051-1052.
48. Csillag, C: HIV-1 subtype C in Brazil. Lancel 1994, 344:1354.
49. van Harmelen J, Wood R, Lambrick M, et al. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 1997, 11:81-87.
50. Peelers M, Vincent R, Perret J-L, et al. Evidence for differences in MT2 cell tropism according to genetic subtypes of HIV-1: syncytium-inducing variants seem rare among C HIV-1 virus. J AIDS Res Hum Relrovir 1999, 20:115-121.
51. Zhang L, Caruthers DDC, He T, et al. HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism. AIDS Res Hum Retrovir1997, 13:1357-1366.
52. Zhang L, Huang Y, He T, Cao Y, Ho DD. HIV-1 subtype and second-receptor use. Nature 1996, 383:768.
53. Connor RI, Kristine SE, Ceradini D, Sunny C, Nathaniel LR. Change in co-receptor use correlates; with disease progression in HIV-1 infected individuals. I Exp JVfed 1997, 183:621-628.